Saba Asghari Kaleibar, Ali Riazi, Farhad Mirzaee, Ata Mahdkhah
{"title":"Ibrahim Ozdemir等人致编辑的关于“贝尔氏麻痹引起的急性lagophthalmmos可能是COVID-19的征兆”的信。","authors":"Saba Asghari Kaleibar, Ali Riazi, Farhad Mirzaee, Ata Mahdkhah","doi":"10.1080/01658107.2021.1996613","DOIUrl":null,"url":null,"abstract":"We read with enormous attention the paper by Ozdemir et al. highlighting the possibility of an association between severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and lagophthalmos due to Bell’s palsy (BP). We are grateful for the views of the authors to encourage discussion on significant aspects of clinical manifestations of coronavirus infection (COVID-19). As a result, we wish to present some of our comments related to this valuable article. First of all, clinical symptoms and signs of central nervous system (CNS) and peripheral nervous system (PNS) involvement can be detected in up to 25% of coronavirus infected patients. Some researchers suggest the term ”Neuro-COVID syndrome” for presentations with pure CNS and PNS involvement at onset. Based on the iterature, there are more than 21 clinical manifestations of neurological disorders in these patients. Some authors believe that there is an association between COVID-19 and BP due to a neuro-immunological process involving microbial and nerve antigens. Moreover, you can find an association between COVID-19 immunisation and BP in the literature. Another important problem in the management of patients with BP is the role of immunosuppressants like glucocorticoids. Can these medications lead to a flare up of hidden COVID-19 activity in infected patients? On the other hand, the data show that broad suppression of immune reactions during acute severe COVID-19 can be beneficial in higher risk patients using glucocorticoids. The authors concluded that lagopthalmos due to BP could be a sign of COVID-19. As a result, how we can treat the patients with both COVID-19 and BP? These questions may be answered in the future. In the end, the nature of the study, the narrow inclusion and exclusion criteria and the small sample size can be limiting. We once again appreciate the authors for this research and hope that our explanation will help this valuable journal’s readership.","PeriodicalId":19257,"journal":{"name":"Neuro-Ophthalmology","volume":" ","pages":"59-60"},"PeriodicalIF":0.8000,"publicationDate":"2021-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8794245/pdf/IOPH_46_1996613.pdf","citationCount":"0","resultStr":"{\"title\":\"Letter to Editor on \\\"Acute Lagophthalmos Due to Bell's Palsy Could Be a Sign of COVID-19\\\" by Ibrahim Ozdemir et al.\",\"authors\":\"Saba Asghari Kaleibar, Ali Riazi, Farhad Mirzaee, Ata Mahdkhah\",\"doi\":\"10.1080/01658107.2021.1996613\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"We read with enormous attention the paper by Ozdemir et al. highlighting the possibility of an association between severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and lagophthalmos due to Bell’s palsy (BP). We are grateful for the views of the authors to encourage discussion on significant aspects of clinical manifestations of coronavirus infection (COVID-19). As a result, we wish to present some of our comments related to this valuable article. First of all, clinical symptoms and signs of central nervous system (CNS) and peripheral nervous system (PNS) involvement can be detected in up to 25% of coronavirus infected patients. Some researchers suggest the term ”Neuro-COVID syndrome” for presentations with pure CNS and PNS involvement at onset. Based on the iterature, there are more than 21 clinical manifestations of neurological disorders in these patients. Some authors believe that there is an association between COVID-19 and BP due to a neuro-immunological process involving microbial and nerve antigens. Moreover, you can find an association between COVID-19 immunisation and BP in the literature. Another important problem in the management of patients with BP is the role of immunosuppressants like glucocorticoids. Can these medications lead to a flare up of hidden COVID-19 activity in infected patients? On the other hand, the data show that broad suppression of immune reactions during acute severe COVID-19 can be beneficial in higher risk patients using glucocorticoids. The authors concluded that lagopthalmos due to BP could be a sign of COVID-19. As a result, how we can treat the patients with both COVID-19 and BP? These questions may be answered in the future. In the end, the nature of the study, the narrow inclusion and exclusion criteria and the small sample size can be limiting. We once again appreciate the authors for this research and hope that our explanation will help this valuable journal’s readership.\",\"PeriodicalId\":19257,\"journal\":{\"name\":\"Neuro-Ophthalmology\",\"volume\":\" \",\"pages\":\"59-60\"},\"PeriodicalIF\":0.8000,\"publicationDate\":\"2021-11-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8794245/pdf/IOPH_46_1996613.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Neuro-Ophthalmology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1080/01658107.2021.1996613\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2022/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q4\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neuro-Ophthalmology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/01658107.2021.1996613","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/1/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
Letter to Editor on "Acute Lagophthalmos Due to Bell's Palsy Could Be a Sign of COVID-19" by Ibrahim Ozdemir et al.
We read with enormous attention the paper by Ozdemir et al. highlighting the possibility of an association between severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and lagophthalmos due to Bell’s palsy (BP). We are grateful for the views of the authors to encourage discussion on significant aspects of clinical manifestations of coronavirus infection (COVID-19). As a result, we wish to present some of our comments related to this valuable article. First of all, clinical symptoms and signs of central nervous system (CNS) and peripheral nervous system (PNS) involvement can be detected in up to 25% of coronavirus infected patients. Some researchers suggest the term ”Neuro-COVID syndrome” for presentations with pure CNS and PNS involvement at onset. Based on the iterature, there are more than 21 clinical manifestations of neurological disorders in these patients. Some authors believe that there is an association between COVID-19 and BP due to a neuro-immunological process involving microbial and nerve antigens. Moreover, you can find an association between COVID-19 immunisation and BP in the literature. Another important problem in the management of patients with BP is the role of immunosuppressants like glucocorticoids. Can these medications lead to a flare up of hidden COVID-19 activity in infected patients? On the other hand, the data show that broad suppression of immune reactions during acute severe COVID-19 can be beneficial in higher risk patients using glucocorticoids. The authors concluded that lagopthalmos due to BP could be a sign of COVID-19. As a result, how we can treat the patients with both COVID-19 and BP? These questions may be answered in the future. In the end, the nature of the study, the narrow inclusion and exclusion criteria and the small sample size can be limiting. We once again appreciate the authors for this research and hope that our explanation will help this valuable journal’s readership.
期刊介绍:
Neuro-Ophthalmology publishes original papers on diagnostic methods in neuro-ophthalmology such as perimetry, neuro-imaging and electro-physiology; on the visual system such as the retina, ocular motor system and the pupil; on neuro-ophthalmic aspects of the orbit; and on related fields such as migraine and ocular manifestations of neurological diseases.